Literature DB >> 15491815

Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes.

Elizabeth Chambers1, Samir Mitragotri.   

Abstract

Polymeric nanoparticles have been extensively studied for use as intravascular drug delivery vehicles; however, their applications are limited by rapid clearance from circulation by the reticuloendothelial system (RES). Previous attempts to improve vascular circulation have focused on surface modification using polymers such as poloxamines, poloxamers, and polyethylene glycol, to prevent opsononization. We report on a novel method of prolonging intravascular particle circulation by anchoring the nanoparticles to the surface of red blood cells (RBCs). We hypothesize that particles adhered to RBCs can escape RES clearance due to the ability of RBCs to do so. This method is motivated by the strategy adopted by certain bacteria, for example, hemobartonella, that adhere to RBCs and remain in circulation for several weeks. Prolonged circulation of nanoparticles as large as 450 nm was observed after adsorption on RBCs. Although particles were eventually eliminated from circulation, RBCs were not cleared. RBC-anchored nanoparticles offer a novel approach for intravascular drug delivery and blood pool imaging.

Entities:  

Mesh:

Year:  2004        PMID: 15491815     DOI: 10.1016/j.jconrel.2004.08.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  41 in total

1.  Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties.

Authors:  Neha B Shah; Gregory M Vercellotti; James G White; Adrian Fegan; Carston R Wagner; John C Bischof
Journal:  Mol Pharm       Date:  2012-07-23       Impact factor: 4.939

Review 2.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 3.  Bio-inspired, bioengineered and biomimetic drug delivery carriers.

Authors:  Jin-Wook Yoo; Darrell J Irvine; Dennis E Discher; Samir Mitragotri
Journal:  Nat Rev Drug Discov       Date:  2011-07-01       Impact factor: 84.694

Review 4.  Red blood cells as an efficient in vitro model for evaluating the efficacy of metallic nanoparticles.

Authors:  Ridhima Wadhwa; Taru Aggarwal; Noopur Thapliyal; Ashutosh Kumar; Pooja Yadav; Vandana Kumari; Boda Sai Charan Reddy; Pranjal Chandra; Pawan Kumar Maurya
Journal:  3 Biotech       Date:  2019-06-21       Impact factor: 2.406

5.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

Review 6.  Synthetic Receptor-Based Targeting Strategies to Improve Tumor Drug Delivery.

Authors:  Susheel Kumar Nethi; Shubhmita Bhatnagar; Swayam Prabha
Journal:  AAPS PharmSciTech       Date:  2021-03-08       Impact factor: 3.246

7.  Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes.

Authors:  Peter Popp Wibroe; Aaron C Anselmo; Per H Nilsson; Apoorva Sarode; Vivek Gupta; Rudolf Urbanics; Janos Szebeni; Alan Christy Hunter; Samir Mitragotri; Tom Eirik Mollnes; Seyed Moein Moghimi
Journal:  Nat Nanotechnol       Date:  2017-04-10       Impact factor: 39.213

Review 8.  Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods.

Authors:  Bishnu P Joshi; Joseph Hardie; Michelle E Farkas
Journal:  Chemistry       Date:  2018-05-14       Impact factor: 5.236

9.  Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile.

Authors:  Juan-Carlos Murciano; Abd Al-Roof Higazi; Douglas B Cines; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2009-07-16       Impact factor: 9.776

Review 10.  Non-affinity factors modulating vascular targeting of nano- and microcarriers.

Authors:  Jacob W Myerson; Aaron C Anselmo; Yaling Liu; Samir Mitragotri; David M Eckmann; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2015-10-24       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.